Bid for mylan. The price tag 40 billion, the largest potential takeover in the drug industry this year. The shares of mylan soared 8 and the shares for teva were higher. This could change the landscape of the industry but there is no guarantee anything about it will be easy. Megan tirrell has more. Another day and another deal in the drug industry. Nevas offer for rival mylan comes on the heels of mylans offer to buy periggo, a move some expected to be defensive. It contributed to deal activity among drug companies. You have to be big or you will get acquired. But mylan is not expected to go easily. Y rejected the idea of a merger with teva saying it will be a cultural clash and could raise antitrust concerned and teva dismissed that today and said they could close the deal by the end of the year. The Israeli Company said they could create a transformative generic drug company with revenue of 30 billion and there could be 2 billion in cost cuts it anticipated. Teva makes the multiple s
The trial began prosecutors representing people of the United States urge adjure to choose death as the punishment for the boston bomber. Four people were killed and 260 wounded almost exactly two years ago. Don dahler says prosecutors opened today with a surprise. Reporter prosecutors came out swinging, telling jurors tsarnaev, seen making an obscene gesture at a camera in a Court Holding cell just three months after the bombings was unconcerned, unrepentd nt and unchanged. He had one more message left to send. During her Opening Statements framed by photos of those killed during the attacks and in the aftermath, assistant attorney Nadine Pelligrini said he planned and plotted to kill, he deliberately selected a glorious sporting event and twisted the marathon into something cruel and ugly for his own purposes. The jury sat rapt as more victims took the stand. Celeste corcoran described being thrown into the air by the blast that destroyed both her legs. I was in such excruciating pai
In houston. Energy is a big story today as it has been every day recently. We will get to brian in a minutes time. First we begin with the growing fears of how vulnerable airlines are to hackers and whether a plane can be brought down by a cyber attack. In San Francisco, live at the largest Information Security event in the world, what are we hearing . This is as you say a big Cyber Security conference. They are just about to open the doors for the beginning of the conference, but controversy and researcher Chris Roberts was on the way to the conference last week. He tweeted out information alleging that he can hack into airplane cockpit systems based on some of the infrastructure inside an airplane. He tweeted that out on wednesday when he arrived at his destination on wednesday. He was met by security at the airport and detained by the fbi for several hours of questioning and conversation. He also said that on saturday as he was on the way here to San Francisco to come to this event,
Bid for mylan. The price tag 40 billion, the largest potential takeover in the drug industry this year. The shares of mylan soared 8 and the shares for teva were higher. This could change the landscape of the industry but there is no guarantee anything about it will be easy. Megan tirrell has more. Another day and another deal in the drug industry. Nevas offer for rival mylan comes on the heels of mylans offer to buy periggo, a move some expected to be defensive. It contributed to deal activity among drug companies. You have to be big or you will get acquired. But mylan is not expected to go easily. Y rejected the idea of a merger with teva saying it will be a cultural clash and could raise antitrust concerned and teva dismissed that today and said they could close the deal by the end of the year. The Israeli Company said they could create a transformative generic drug company with revenue of 30 billion and there could be 2 billion in cost cuts it anticipated. Teva makes the multiple s
Bid for mylan. The price tag 40 billion, the largest potential takeover in the drug industry this year. The shares of mylan soared 8 and the shares for teva were higher. This could change the landscape of the industry but there is no guarantee anything about it will be easy. Megan tirrell has more. Another day and another deal in the drug industry. Nevas offer for rival mylan comes on the heels of mylans offer to buy periggo, a move some expected to be defensive. It contributed to deal activity among drug companies. You have to be big or you will get acquired. But mylan is not expected to go easily. Y rejected the idea of a merger with teva saying it will be a cultural clash and could raise antitrust concerned and teva dismissed that today and said they could close the deal by the end of the year. The Israeli Company said they could create a transformative generic drug company with revenue of 30 billion and there could be 2 billion in cost cuts it anticipated. Teva makes the multiple s